In CTCL, cytotoxic CD4+ T cells act through a granzyme-perforin-dependent pathway to achieve tumor cell killing48,49, similar to cytotoxic CD8+ T cells49–51. Here, PRF1 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.